English
简体中文
Total: £ 56.28
Published Date: 2026-02-03 | Pages: 104 | Tables: 107 | Medical Care
The global Paediatric Influenza Treatment market was valued at US$ 608 million in 2025 and is anticipated to reach US$ 770 million by 2032, at a CAGR of 3.5% from 2026 to 2032.
Pediatric influenza treatment involves specialized medical care and medications tailored to treat influenza (flu) in children. This includes antiviral medications, such as oseltamivir, to reduce the severity and duration of symptoms, along with supportive care like hydration, fever control, and rest. Since children are particularly vulnerable to flu complications, prompt treatment and monitoring are essential to prevent serious outcomes, especially in infants and young children with weakened immune systems.
The North American market for Paediatric Influenza Treatment is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Paediatric Influenza Treatment is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Paediatric Influenza Treatment in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Paediatric Influenza Treatment include GlaxoSmithKline, NATCO Pharma, NESHER PHARMS, Roche, Atabay Kimya Sanayi ve Ticaret, Cipla, Hetero Pharma, Teva Pharmaceutical, Olainfarm, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Paediatric Influenza Treatment market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Paediatric Influenza Treatment. The Paediatric Influenza Treatment market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Paediatric Influenza Treatment market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Paediatric Influenza Treatment manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
GlaxoSmithKline
NATCO Pharma
NESHER PHARMS
Roche
Atabay Kimya Sanayi ve Ticaret
Cipla
Hetero Pharma
Teva Pharmaceutical
Olainfarm
Segment by Type
Oseltamivir
Zanamivir
Amantadine
Rimantadine
Other
Segment by Application
Hospital
Retail Pharmacy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Paediatric Influenza Treatment companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Paediatric Influenza Treatment Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Oseltamivir
1.2.3 Zanamivir
1.2.4 Amantadine
1.2.5 Rimantadine
1.2.6 Other
1.3 Market by Application
1.3.1 Global Paediatric Influenza Treatment Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Paediatric Influenza Treatment Market Perspective (2021–2032)
2.2 Global Paediatric Influenza Treatment Growth Trends by Region
2.2.1 Global Paediatric Influenza Treatment Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Paediatric Influenza Treatment Historic Market Size by Region (2021–2026)
2.2.3 Paediatric Influenza Treatment Forecasted Market Size by Region (2027–2032)
2.3 Paediatric Influenza Treatment Market Dynamics
2.3.1 Paediatric Influenza Treatment Industry Trends
2.3.2 Paediatric Influenza Treatment Market Drivers
2.3.3 Paediatric Influenza Treatment Market Challenges
2.3.4 Paediatric Influenza Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Paediatric Influenza Treatment Players by Revenue
3.1.1 Global Top Paediatric Influenza Treatment Players by Revenue (2021–2026)
3.1.2 Global Paediatric Influenza Treatment Revenue Market Share by Players (2021–2026)
3.2 Global Top Paediatric Influenza Treatment Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Paediatric Influenza Treatment Revenue
3.4 Global Paediatric Influenza Treatment Market Concentration Ratio
3.4.1 Global Paediatric Influenza Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Paediatric Influenza Treatment Revenue in 2025
3.5 Global Key Players of Paediatric Influenza Treatment Head Offices and Areas Served
3.6 Global Key Players of Paediatric Influenza Treatment, Products and Applications
3.7 Global Key Players of Paediatric Influenza Treatment, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Paediatric Influenza Treatment Breakdown Data by Type
4.1 Global Paediatric Influenza Treatment Historic Market Size by Type (2021–2026)
4.2 Global Paediatric Influenza Treatment Forecasted Market Size by Type (2027–2032)
5 Paediatric Influenza Treatment Breakdown Data by Application
5.1 Global Paediatric Influenza Treatment Historic Market Size by Application (2021–2026)
5.2 Global Paediatric Influenza Treatment Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Paediatric Influenza Treatment Market Size (2021–2032)
6.2 North America Paediatric Influenza Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Paediatric Influenza Treatment Market Size by Country (2021–2026)
6.4 North America Paediatric Influenza Treatment Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Paediatric Influenza Treatment Market Size (2021–2032)
7.2 Europe Paediatric Influenza Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Paediatric Influenza Treatment Market Size by Country (2021–2026)
7.4 Europe Paediatric Influenza Treatment Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Paediatric Influenza Treatment Market Size (2021–2032)
8.2 Asia-Pacific Paediatric Influenza Treatment Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Paediatric Influenza Treatment Market Size by Region (2021–2026)
8.4 Asia-Pacific Paediatric Influenza Treatment Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Paediatric Influenza Treatment Market Size (2021–2032)
9.2 Latin America Paediatric Influenza Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Paediatric Influenza Treatment Market Size by Country (2021–2026)
9.4 Latin America Paediatric Influenza Treatment Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Paediatric Influenza Treatment Market Size (2021–2032)
10.2 Middle East & Africa Paediatric Influenza Treatment Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Paediatric Influenza Treatment Market Size by Country (2021–2026)
10.4 Middle East & Africa Paediatric Influenza Treatment Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Paediatric Influenza Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.1.5 GlaxoSmithKline Recent Development
11.2 NATCO Pharma
11.2.1 NATCO Pharma Company Details
11.2.2 NATCO Pharma Business Overview
11.2.3 NATCO Pharma Paediatric Influenza Treatment Introduction
11.2.4 NATCO Pharma Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.2.5 NATCO Pharma Recent Development
11.3 NESHER PHARMS
11.3.1 NESHER PHARMS Company Details
11.3.2 NESHER PHARMS Business Overview
11.3.3 NESHER PHARMS Paediatric Influenza Treatment Introduction
11.3.4 NESHER PHARMS Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.3.5 NESHER PHARMS Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Paediatric Influenza Treatment Introduction
11.4.4 Roche Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.4.5 Roche Recent Development
11.5 Atabay Kimya Sanayi ve Ticaret
11.5.1 Atabay Kimya Sanayi ve Ticaret Company Details
11.5.2 Atabay Kimya Sanayi ve Ticaret Business Overview
11.5.3 Atabay Kimya Sanayi ve Ticaret Paediatric Influenza Treatment Introduction
11.5.4 Atabay Kimya Sanayi ve Ticaret Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.5.5 Atabay Kimya Sanayi ve Ticaret Recent Development
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Paediatric Influenza Treatment Introduction
11.6.4 Cipla Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.6.5 Cipla Recent Development
11.7 Hetero Pharma
11.7.1 Hetero Pharma Company Details
11.7.2 Hetero Pharma Business Overview
11.7.3 Hetero Pharma Paediatric Influenza Treatment Introduction
11.7.4 Hetero Pharma Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.7.5 Hetero Pharma Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Paediatric Influenza Treatment Introduction
11.8.4 Teva Pharmaceutical Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.8.5 Teva Pharmaceutical Recent Development
11.9 Olainfarm
11.9.1 Olainfarm Company Details
11.9.2 Olainfarm Business Overview
11.9.3 Olainfarm Paediatric Influenza Treatment Introduction
11.9.4 Olainfarm Revenue in Paediatric Influenza Treatment Business (2021–2026)
11.9.5 Olainfarm Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Paediatric Influenza Treatment Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Oseltamivir
Table 3. Key Players of Zanamivir
Table 4. Key Players of Amantadine
Table 5. Key Players of Rimantadine
Table 6. Key Players of Other
Table 7. Global Paediatric Influenza Treatment Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Paediatric Influenza Treatment Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Paediatric Influenza Treatment Market Size by Region (US$ Million), 2021–2026
Table 10. Global Paediatric Influenza Treatment Market Share by Region (2021–2026)
Table 11. Global Paediatric Influenza Treatment Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Paediatric Influenza Treatment Market Share by Region (2027–2032)
Table 13. Paediatric Influenza Treatment Market Trends
Table 14. Paediatric Influenza Treatment Market Drivers
Table 15. Paediatric Influenza Treatment Market Challenges
Table 16. Paediatric Influenza Treatment Market Restraints
Table 17. Global Paediatric Influenza Treatment Revenue by Players (US$ Million), 2021–2026
Table 18. Global Paediatric Influenza Treatment Market Share by Players (2021–2026)
Table 19. Global Top Paediatric Influenza Treatment Players by Tier (Tier 1, Tier 2, and Tier 3), based on Paediatric Influenza Treatment Revenue, 2025
Table 20. Ranking of Global Top Paediatric Influenza Treatment Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Paediatric Influenza Treatment Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Paediatric Influenza Treatment, Headquarters and Area Served
Table 23. Global Key Players of Paediatric Influenza Treatment, Products and Applications
Table 24. Global Key Players of Paediatric Influenza Treatment, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Paediatric Influenza Treatment Market Size by Type (US$ Million), 2021–2026
Table 27. Global Paediatric Influenza Treatment Revenue Market Share by Type (2021–2026)
Table 28. Global Paediatric Influenza Treatment Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Paediatric Influenza Treatment Revenue Market Share by Type (2027–2032)
Table 30. Global Paediatric Influenza Treatment Market Size by Application (US$ Million), 2021–2026
Table 31. Global Paediatric Influenza Treatment Revenue Market Share by Application (2021–2026)
Table 32. Global Paediatric Influenza Treatment Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Paediatric Influenza Treatment Revenue Market Share by Application (2027–2032)
Table 34. North America Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 36. North America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Paediatric Influenza Treatment Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Paediatric Influenza Treatment Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Paediatric Influenza Treatment Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Paediatric Influenza Treatment Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Paediatric Influenza Treatment Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Paediatric Influenza Treatment Market Size by Country (US$ Million), 2027–2032
Table 49. GlaxoSmithKline Company Details
Table 50. GlaxoSmithKline Business Overview
Table 51. GlaxoSmithKline Paediatric Influenza Treatment Product
Table 52. GlaxoSmithKline Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 53. GlaxoSmithKline Recent Development
Table 54. NATCO Pharma Company Details
Table 55. NATCO Pharma Business Overview
Table 56. NATCO Pharma Paediatric Influenza Treatment Product
Table 57. NATCO Pharma Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 58. NATCO Pharma Recent Development
Table 59. NESHER PHARMS Company Details
Table 60. NESHER PHARMS Business Overview
Table 61. NESHER PHARMS Paediatric Influenza Treatment Product
Table 62. NESHER PHARMS Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 63. NESHER PHARMS Recent Development
Table 64. Roche Company Details
Table 65. Roche Business Overview
Table 66. Roche Paediatric Influenza Treatment Product
Table 67. Roche Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 68. Roche Recent Development
Table 69. Atabay Kimya Sanayi ve Ticaret Company Details
Table 70. Atabay Kimya Sanayi ve Ticaret Business Overview
Table 71. Atabay Kimya Sanayi ve Ticaret Paediatric Influenza Treatment Product
Table 72. Atabay Kimya Sanayi ve Ticaret Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 73. Atabay Kimya Sanayi ve Ticaret Recent Development
Table 74. Cipla Company Details
Table 75. Cipla Business Overview
Table 76. Cipla Paediatric Influenza Treatment Product
Table 77. Cipla Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 78. Cipla Recent Development
Table 79. Hetero Pharma Company Details
Table 80. Hetero Pharma Business Overview
Table 81. Hetero Pharma Paediatric Influenza Treatment Product
Table 82. Hetero Pharma Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 83. Hetero Pharma Recent Development
Table 84. Teva Pharmaceutical Company Details
Table 85. Teva Pharmaceutical Business Overview
Table 86. Teva Pharmaceutical Paediatric Influenza Treatment Product
Table 87. Teva Pharmaceutical Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 88. Teva Pharmaceutical Recent Development
Table 89. Olainfarm Company Details
Table 90. Olainfarm Business Overview
Table 91. Olainfarm Paediatric Influenza Treatment Product
Table 92. Olainfarm Revenue in Paediatric Influenza Treatment Business (US$ Million), 2021–2026
Table 93. Olainfarm Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
Table 97. Authors List of This Report
List of Figures
Figure 1. Paediatric Influenza Treatment Picture
Figure 2. Global Paediatric Influenza Treatment Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Paediatric Influenza Treatment Market Share by Type: 2025 vs 2032
Figure 4. Oseltamivir Features
Figure 5. Zanamivir Features
Figure 6. Amantadine Features
Figure 7. Rimantadine Features
Figure 8. Other Features
Figure 9. Global Paediatric Influenza Treatment Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Paediatric Influenza Treatment Market Share by Application: 2025 vs 2032
Figure 11. Hospital Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Other Case Studies
Figure 14. Paediatric Influenza Treatment Report Years Considered
Figure 15. Global Paediatric Influenza Treatment Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Paediatric Influenza Treatment Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Paediatric Influenza Treatment Market Share by Region: 2025 vs 2032
Figure 18. Global Paediatric Influenza Treatment Market Share by Players in 2025
Figure 19. Global Paediatric Influenza Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Paediatric Influenza Treatment Revenue in 2025
Figure 21. North America Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 23. United States Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 27. Germany Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Paediatric Influenza Treatment Market Share by Region (2021–2032)
Figure 35. China Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 43. Mexico Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Paediatric Influenza Treatment Market Share by Country (2021–2032)
Figure 47. Israel Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Paediatric Influenza Treatment Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. GlaxoSmithKline Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 51. NATCO Pharma Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 52. NESHER PHARMS Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 53. Roche Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 54. Atabay Kimya Sanayi ve Ticaret Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 55. Cipla Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 56. Hetero Pharma Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 57. Teva Pharmaceutical Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 58. Olainfarm Revenue Growth Rate in Paediatric Influenza Treatment Business (2021–2026)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
